Works matching IS 17501326 AND DT 2007 AND VI 2
Results: 23
Differential expression of interferon responsive genes in rodentmodels of transmissible spongiform encephalopathy disease.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 5, doi. 10.1186/1750-1326-2-5
- Publication type:
- Article
Tau phosphorylation by GSK-3β promotes tangle-like filament morphology.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 12, doi. 10.1186/1750-1326-2-12
- By:
- Publication type:
- Article
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 11, doi. 10.1186/1750-1326-2-11
- By:
- Publication type:
- Article
Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 1, doi. 10.1186/1750-1326-2-10
- By:
- Publication type:
- Article
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 1, doi. 10.1186/1750-1326-2-7
- By:
- Publication type:
- Article
Design of a novel quantitative PCR (QPCR)-based protocol forgenotyping mice carrying the neuroprotective Walleriandegeneration slow (Wld<sup>s</sup>) gene.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 21, doi. 10.1186/1750-1326-2-21
- Publication type:
- Article
The Alzheimer's disease β-secretase enzyme, BACE1.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 22, doi. 10.1186/1750-1326-2-22
- By:
- Publication type:
- Article
Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 23, doi. 10.1186/1750-1326-2-23
- By:
- Publication type:
- Article
Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 20, doi. 10.1186/1750-1326-2-20
- By:
- Publication type:
- Article
Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 1, doi. 10.1186/1750-1326-2-1
- By:
- Publication type:
- Article
Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 19, doi. 10.1186/1750-1326-2-19
- By:
- Publication type:
- Article
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 18, doi. 10.1186/1750-1326-2-18
- By:
- Publication type:
- Article
An AICD-based functional screen to identify APP metabolism regulators.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 15, doi. 10.1186/1750-1326-2-15
- By:
- Publication type:
- Article
Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 9, doi. 10.1186/1750-1326-2-9
- By:
- Publication type:
- Article
Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 8, doi. 10.1186/1750-1326-2-8
- By:
- Publication type:
- Article
Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 6, doi. 10.1186/1750-1326-2-6
- By:
- Publication type:
- Article
From a Parkinson's disease expert: Rasagiline and the Future of Therapy.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 13, doi. 10.1186/1750-1326-2-13
- By:
- Publication type:
- Article
Dual roles of the transmembrane protein p23/TMP21 in the modulation of amyloid precursor protein metabolism.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 4, doi. 10.1186/1750-1326-2-4
- By:
- Publication type:
- Article
APP-BP1 inhibits Aβ42 levels by interacting with Presenilin-1.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 3, doi. 10.1186/1750-1326-2-3
- By:
- Publication type:
- Article
Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 2, doi. 10.1186/1750-1326-2-2
- By:
- Publication type:
- Article
Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 17, doi. 10.1186/1750-1326-2-17
- By:
- Publication type:
- Article
Design of an improved set of oligonucleotide primers for genotyping MeCP2<sup>tm1.1 Bird</sup> KO mice by PCR.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 1, doi. 10.1186/1750-1326-2-16
- By:
- Publication type:
- Article
ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity.
- Published in:
- Molecular Neurodegeneration, 2007, v. 2, p. 14, doi. 10.1186/1750-1326-2-14
- By:
- Publication type:
- Article